Standards; Chiral Molecules; Pharmaceutical/API Drug Impurities/Metabolites;
應用
Isavuconazole is a new triazole currently undergoing phase III clinical trials. This compound has shown in vitro activity against a large number of clinical important yeasts and molds including Aspergillus spp., Fusarium spp., Scedosporium spp., Candida spp., the Zygomycetes and Cryptococcus spp.
滬ICP備17019645號
400-821-0725
